ADVFN - Advanced Financial Network.
HOME» NASDAQ » I » ILMN Stock Price » ILMN Stock News

Illumina Share News

 Illumina (mm) Stock Price
ILMN Stock Price
 Illumina (mm) Stock Chart
ILMN Stock Chart
 Illumina (mm) Stock News
ILMN Stock News
 Illumina (mm) Company Information
ILMN Company Information
 Illumina (mm) Stock Trades
ILMN Stock Trades

Roche Doesn't Plan To Extend Bid For Illumina

DOW JONES NEWSWIRES Roche Holding AG (ROG.VX) said it doesn't plan to extend its unsolicited takeover bid worth more than $6.5 billion for Illumina Inc. (ILMN) past Friday's deadline, citing preliminary estimates indicating that the incumbents on the U.S. gene-sequencing company's will be re-elected. "We do not believe that a price above Roche's offer for Illumina of $51 per share would be in the interest of Roche's shareholders," Roche Chief Executive Severin Schwan said. Ilumina shares were down 9% at $40 in recent premarket trading. Through Wednesday's close the stock was up 44% this year amid the takeover offer. A Roche unit had proposed amending Illumina's bylaws to increase the number of directors on its board and offered two individuals to fill the new slots. If all Roche's proposals were adopted and its nominees elected, Roche's nominees would have constituted a majority of Illumina's board. Three proxy advisory firms had recommended that Illumina's shareholders vote against Roche's slate, and Illumina's board has recommended shareholders reject the proposals. Roche recently raised its offer for Illumina, but the company has continued to spurn the offer as undervaluing its "extraordinary" growth prospects. Roche has called its bid "full, fair and extremely attractive." The world's largest maker of cancer drugs had launched the hostile takeover attempt in late January in part of a search for ways to expand its offerings in the burgeoning personalized-medicine market. -By Tess Stynes and Joan E. Solsman, Dow Jones Newswires; 212-416-2481;

Stock News for Illumina (ILMN)
10/10/201509:54:49Trouble Just Beginning For Illumina
10/07/201519:47:18Statement of Changes in Beneficial Ownership (4)
10/07/201506:30:00Illumina Introduces Genomics Solutions to Advance Clinical Research
10/06/201506:30:00Illumina Expands Use of HiSeq X™ Sequencing System to Include N...
10/05/201519:55:24Amended Statement of Changes in Beneficial Ownership (4/a)
10/05/201516:08:23Current Report Filing (8-k)
10/05/201516:05:00Illumina Announces Preliminary Revenue for Third Quarter of Fiscal...
10/02/201518:25:12Statement of Changes in Beneficial Ownership (4)
10/02/201518:21:03Statement of Changes in Beneficial Ownership (4)
10/01/201517:48:44Statement of Changes in Beneficial Ownership (4)
10/01/201506:30:00Illumina Expands World’s Largest Genomics Analysis Platform a...
09/30/201520:00:00Amoy Diagnostics and Illumina Enter Strategic Collaboration...
09/30/201508:03:00Biotechnology Equity Picks -- Arena Pharma, Biogen, Omeros, Illumina...
09/29/201516:28:13Statement of Changes in Beneficial Ownership (4)
09/29/201506:30:00Illumina Launches TruSight® Tumor OncoPanel
09/28/201519:12:42Statement of Changes in Beneficial Ownership (4)
09/23/201512:43:12Statement of Changes in Beneficial Ownership (4)
09/23/201506:30:00Illumina Joins WIN Consortium in Personalized Cancer Medicine
09/17/201519:40:15Statement of Changes in Beneficial Ownership (4)
09/16/201515:20:08Statement of Changes in Beneficial Ownership (4)

Illumina and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations